5-[(4R,9aS)-4-methyl-8-(5,6,7,8-tetrahydro-2,7-naphthyridin-4-yl)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-2-yl]quinoline-8-carbonitrile

ID: ALA4745246

PubChem CID: 155191925

Max Phase: Preclinical

Molecular Formula: C26H29N7

Molecular Weight: 439.57

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@@H]1CN(c2ccc(C#N)c3ncccc23)C[C@H]2CN(c3cncc4c3CCNC4)CCN21

Standard InChI:  InChI=1S/C26H29N7/c1-18-15-32(24-5-4-19(11-27)26-23(24)3-2-7-30-26)17-21-16-31(9-10-33(18)21)25-14-29-13-20-12-28-8-6-22(20)25/h2-5,7,13-14,18,21,28H,6,8-10,12,15-17H2,1H3/t18-,21-/m1/s1

Standard InChI Key:  RPHHNWILYSFFFK-WIYYLYMNSA-N

Molfile:  

 
     RDKit          2D

 34 39  0  0  0  0  0  0  0  0999 V2000
   27.4024   -8.6233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4012   -9.4507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1166   -9.8656    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.1148   -8.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8307   -8.6196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8315   -9.4464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5432   -9.8595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2588   -9.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2541   -8.6127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5377   -8.2076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5449  -10.6845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5476  -11.5075    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.5333   -7.3826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2506   -6.9673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8222   -6.1484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8230   -6.9761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5328   -5.7354    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2502   -6.1476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9639   -5.7381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9665   -4.9108    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2490   -4.4945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5291   -4.9098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6822   -4.4990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1138   -3.6779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1120   -4.5037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.3955   -4.9153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1064   -5.7393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9609   -6.5587    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   31.6822   -3.6773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3998   -3.2687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4047   -2.4475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6937   -2.0287    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.9761   -2.4373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9695   -3.2647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  7 11  1  0
 11 12  3  0
 10 13  1  0
 13 14  1  0
 13 16  1  0
 14 18  1  0
 17 15  1  0
 15 16  1  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 23 26  2  0
 25 24  2  0
 24 30  1  0
 29 23  1  0
 20 23  1  0
 25 26  1  0
 15 27  1  1
 18 28  1  1
 29 30  2  0
 29 34  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4745246

    ---

Associated Targets(Human)

TLR9 Tclin Toll-like receptor 9 (943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR8 Tchem Toll-like receptor 8 (1853 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR7 Tclin Toll-like receptor 7 (2626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.57Molecular Weight (Monoisotopic): 439.2484AlogP: 2.55#Rotatable Bonds: 2
Polar Surface Area: 71.32Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.64CX LogP: 2.54CX LogD: 1.08
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.66Np Likeness Score: -0.88

References

1. Sabnis RW.  (2021)  Novel Hexahydro-1H-Pyrazino[1,2-a]pyrazine Compounds for Treating Autoimmune Diseases.,  12  (1): [PMID:33488956] [10.1021/acsmedchemlett.0c00623]

Source